{"ticker": {"uuid": "409c3dce-9ffc-466e-8832-c9f9a9cb4c81", "symbol": "600329", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Tianjin Da Ren Tang Sees Headline Profit Slump, Core Earnings Edge Higher in 1H 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNMXBTREE1RXFCYV81WE1iZDBlXzNEN3AwTG1ITmhyZHI3TWllN2lCS192LTNLY3pfYjc2dE1JX1pIUDZPM3NFZzR6Y182Zk84T2tfb05mODI3Nm1ORWl2eW5YdGRwTFlUQmx1bWlkb2NzRVg1S2FSVXY3YkJWMDhSb0I2cnk2NURvLW1tNFE5X2JtQnNlMUhzUnduazMzNjdJdXQ4NFBzYktseXRsLVhqNUNWdi00dGhKLVRnU2E4X3R0Z28xMGhkUFUtUGJSSnJ1NDJSNzVFSFVsY09jN25VVWNmZmJBQkg1ZzRKRFJnc1V2UHdaMTRn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-15T10:43:15+00:00", "published_display": "15 Jul 2026 10:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIANJIN PHARMACEUTICAL: Panic buying of drugs in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQQTVtU2YyYXFVd1VtU1ZhcXFjTlhzTVJWOEVpeU5RdzkzN2N3OHpsUV8yX1BBQXpHaDU0TG5fQ3RWUG9McElraXNWSDdBN1J0LTRJMkVjSnVHZDFDLVZMV0cyVHRyRUZwSy05d2dhbkZsak1zbV9vcndyUEplMG9rWmVKeWIwcGc1NEZVNURUS3Y4bGVHUTJtNmYtczJVMktZdm1jV25JN1dhNS1xQmljSEZxeFNQdGZ4Mnc?oc=5", "source_name": "NextInsight", "published_at": "2022-12-20T08:00:00+00:00", "published_display": "20 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brokers' take: Lim & Tan sees strong positives in Tianjin Da Ren Tang; initiates with US$1.60 target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQT3A5STRXbkxEZkVkcnlUT1dHTXlKbWhPcnUzWUIzMUFvT19sNnZGbEE3T2V6cHlFWWpOakdTZHhVMXFCaGxGTEVfSG5vbFZwekV1bEU3ZHhxMV93SXRnUnNKeVBuUnNmcjJvQUQzRU5IQW9meFVRcFJwR2ZnWnF5WTQ2MjJ2N2hrYURDa2tacjEzUVNTU0pQUU5SdUpIY0MxWmUtV3UzTDRCQkowM2U4X1Q3bWotNDAxZW9oUGtjZl8yUEJwTzRiSw?oc=5", "source_name": "The Business Times", "published_at": "2022-08-10T07:00:00+00:00", "published_display": "10 Aug 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Tianjin Da Ren Tang Sees Headline Profit Slump, Core Earnings Edge Higher in 1H 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNMXBTREE1RXFCYV81WE1iZDBlXzNEN3AwTG1ITmhyZHI3TWllN2lCS192LTNLY3pfYjc2dE1JX1pIUDZPM3NFZzR6Y182Zk84T2tfb05mODI3Nm1ORWl2eW5YdGRwTFlUQmx1bWlkb2NzRVg1S2FSVXY3YkJWMDhSb0I2cnk2NURvLW1tNFE5X2JtQnNlMUhzUnduazMzNjdJdXQ4NFBzYktseXRsLVhqNUNWdi00dGhKLVRnU2E4X3R0Z28xMGhkUFUtUGJSSnJ1NDJSNzVFSFVsY09jN25VVWNmZmJBQkg1ZzRKRFJnc1V2UHdaMTRn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-15T10:43:15+00:00", "published_display": "15 Jul 2026 10:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TIANJIN PHARMACEUTICAL: Panic buying of drugs in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQQTVtU2YyYXFVd1VtU1ZhcXFjTlhzTVJWOEVpeU5RdzkzN2N3OHpsUV8yX1BBQXpHaDU0TG5fQ3RWUG9McElraXNWSDdBN1J0LTRJMkVjSnVHZDFDLVZMV0cyVHRyRUZwSy05d2dhbkZsak1zbV9vcndyUEplMG9rWmVKeWIwcGc1NEZVNURUS3Y4bGVHUTJtNmYtczJVMktZdm1jV25JN1dhNS1xQmljSEZxeFNQdGZ4Mnc?oc=5", "source_name": "NextInsight", "published_at": "2022-12-20T08:00:00+00:00", "published_display": "20 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brokers' take: Lim & Tan sees strong positives in Tianjin Da Ren Tang; initiates with US$1.60 target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQT3A5STRXbkxEZkVkcnlUT1dHTXlKbWhPcnUzWUIzMUFvT19sNnZGbEE3T2V6cHlFWWpOakdTZHhVMXFCaGxGTEVfSG5vbFZwekV1bEU3ZHhxMV93SXRnUnNKeVBuUnNmcjJvQUQzRU5IQW9meFVRcFJwR2ZnWnF5WTQ2MjJ2N2hrYURDa2tacjEzUVNTU0pQUU5SdUpIY0MxWmUtV3UzTDRCQkowM2U4X1Q3bWotNDAxZW9oUGtjZl8yUEJwTzRiSw?oc=5", "source_name": "The Business Times", "published_at": "2022-08-10T07:00:00+00:00", "published_display": "10 Aug 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 47, "total_relevant": 3, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 1, "score": 61, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 54, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 37.91, "latest_week": "2026-07-17", "one_week_move": 2.3, "four_week_move": 6.4, "twelve_week_move": -4.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.729779, "market_dynamics_buy_signal": false, "relative_strength": -4.041434, "fair_value_gap": 14.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.4247, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.3% over one week, +6.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "The Globe and Mail", "count": 1}, {"label": "NextInsight", "count": 1}, {"label": "The Business Times", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Market update", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "61/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "54/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.3% over one week, +6.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Tianjin Da Ren Tang Sees Headline Profit Slump, Core Earnings Edge Higher in 1H 2026"}], "updated_at": "2026-07-23T08:23:11.605508+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}